Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Lung Cancer
Both
Lung Cancer
Trial Information
Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer
Inclusion Criteria:
Patients, > 18 years of age,
Gender- Males and Female
Diagnosis of Non Small Cell Lung Cancer.
Patients who have consented on an Ottawa Hospital consent form to undergo a
mediastinoscopy procedure or EBUS-TBNA, and a Positron emission tomography (PET) of the
chest for lung cancer staging.
Exclusion Criteria:
Females who are pregnant (or found to be pregnant) during the course of this research
study.
Patients who do not provide their Ottawa Hospital consent to undergo a staging
bronchoscopy , cervical mediastinoscopy or EBUS-TBNA.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Lung cancer staging
Outcome Description:
Lung cancer staging (assessed by either cervical mediastinoscopy or EBUS) will be compared both pre-op and post-op.
Outcome Time Frame:
Pre-op and post-op
Safety Issue:
No
Authority:
Canada: Ethics Review Committee
Study ID:
2009471-01H
NCT ID:
NCT01799980
Start Date:
June 2012
Completion Date:
Related Keywords:
- Lung Cancer
- Lung cancer
- Cervical mediastinoscopy
- Endobronchial ultrasound
- Staging
- Lung Neoplasms
Name | Location |
|---|
